Evidence map›Paper›PMID 23131784›Full record

ArticleMucosal immunology2013

Functional diversity of human vaginal APC subsets in directing T-cell responses.

D Duluc, J Gannevat, E Anguiano, S Zurawski, M Carley, M Boreham, J Stecher, M Dullaers, J Banchereau, S Oh

Open access · bronzeAbstract read
In one paragraph

Article in Mucosal immunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 87 citations in OpenAlex.

  1. Review
  2. Review
  3. Innate Immune Protection Against HIV in the Female Genital Tract.American journal of reproductive immunology (New York, N.Y. : 1989) · 2026
    Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

D DulucBaylor Institute for Immunology Research, Dallas, Texas, USA.
J Gannevat
E Anguiano
S Zurawski
M Carley
M Boreham
J Stecher
M Dullaers
J Banchereau
S Oh
Baylor University Medical Center · USBaylor Institute for Rehabilitation · USInserm · FR

Funding

Targeting Dendritic Cells for Enhanced Musocal ImmunityU19AI057234 · NIAID · BAYLOR RESEARCH INSTITUTE · PI PALUCKA, ANNA KAROLINA · 2003 to 2013
$49.2M
Targeting Dendritic Cell Subsets in Human Vagina to Elicit Local ImmunityRC1AI087379 · NIAID · BAYLOR RESEARCH INSTITUTE · PI OH, SANGKON · 2010 to 2010
$500k
NIAID NIH HHS 1RC1AI087379-01NIAID NIH HHS RC1 AI087379NIAID NIH HHS U19 AI057234
6 · The paper itself

Abstract

Human vaginal mucosa is the major entry site of sexually transmitted pathogens and thus has long been attractive as a site for mounting mucosal immunity. It is also known as a tolerogenic microenvironment. Here, we demonstrate that immune responses in the vagina can be orchestrated by the functional diversity of four major antigen-presenting cell (APC) subsets. Langerhans cells (LCs) and CD14(-) lamina propria-dendritic cells (LP-DCs) polarize CD4(+) and CD8(+) T cells toward T-helper type 2 (Th2), whereas CD14(+) LP-DCs and macrophages polarize CD4(+) T cells toward Th1. Both LCs and CD14(-) LP-DCs are potent inducers of Th22. Owing to their functional specialties and the different expression levels of pattern-recognition receptors on the APC subsets, microbial products do not bias them to elicit common types of immune responses (Th1 or Th2). To evoke desired types of adaptive immune responses in the human vagina, antigens may need to be targeted to proper APC subsets with right adjuvants.

Indexed as

AdultAgedAged, 80 and overAntigen-Presenting CellsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell DifferentiationCells, CulturedDendritic CellsFemaleHumansImmunity, MucosalImmunomodulationLangerhans CellsLipopolysaccharide ReceptorsLymphocyte ActivationLipopolysaccharide Receptors

Identifiers

PMID23131784
PMCPMC3568194
OpenAlexW1997103485

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.